Nilla Avanzi

The TPM3‐NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition

Andrea Lombardi Borgia, Antonella Isacchi, Roberta Bosotti, 2014, Molecular oncology.

Targeting the mitotic checkpoint for cancer therapy with NMS-P715, an inhibitor of MPS1 kinase.

Antonella Isacchi, Riccardo Colombo, Enrico Pesenti, 2010, Cancer research.

Crystal structures of anaplastic lymphoma kinase in complex with ATP competitive inhibitors.

Andrea Lombardi Borgia, Luisa Rusconi, Tiziano Bandiera, 2010, Biochemistry.